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Background: The use of complementary and alternative medicine (CAM) by patients and physicians has in-
creased markedly in recent years. Many case reports, case series, and uncontrolled trials of varying quality
have been completed; however, there is now a slowly increasing number of randomized controlled trials
(RCTs) examining the use of CAM. Objectives: To identify, survey, and review RCTs investigating the use of
CAM for infertility treatment. Search strategy: The MEDLINE and Cochrane databases were electronically
searched. Selection criteria: RCTs examining modalities for treatment or improvement of health status were
reviewed. Data collection and analysis: RCTs were included based on use of objective measures, articles
written in English, availability through the University of Michigan database, and clear published clinical
outcomes. Main results: Thirty-seven articles assessing a variety of CAM modalities met inclusion criteria.
Acupuncture, selenium supplementation, weight loss, and psychotherapeutic intervention had 3 or more
studies demonstrating beneficial effect. Other interventions had been studied less and evidence for them
was limited. Conclusions: Although there is preliminary evidence of the effectiveness of some CAM interven-
tions among infertile patients, many of these interventions require further investigation before they can be
considered for routine clinical use.
Published by Elsevier Ireland Ltd. on behalf of International Federation of Gynecology and Obstetrics.1. Introduction
The use of complementary and alternative medicine (CAM) by
both infertility patients and physicians has increased markedly over
the past 3 decades [1]. Frequently, patients utilize these therapies in
addition to, or in lieu of, biomedical therapy [2]. Within recent years,
substantial shifts in CAM use have occurred, and studies examining
the scientific basis of these therapies are mounting [1]. Subsequently,
in contemporary practice, an integrated structure is emerging where
biomedical treatment and CAM are blended.
The Cochrane Collaboration defines CAM as “…a broad domain of
healing resources that encompasses all health systems, modalities,
and practices and their accompanying theories and beliefs, other
than those intrinsic to the politically dominant health system of a par-
ticular society or a culture in a given historical period” [3].
Complementary and alternative medicine interventions encompass
a broad range of interventions that act through a variety of measurable
and immeasurable mechanisms. These modalities include, but are
not limited to, homeopathic and herbal medicines, acupuncture and
acupressure, energy healing, massage, specified diets, and psychosociald Gynecology, L4100Women’s
ter, 1500 East Medical Center
4035; fax: +1 734 936 8745.
).
reland Ltd. on behalf of Internationainterventions. A huge number of case reports, case series, and uncon-
trolled trials of varying quality have been executed examining CAM.
Fortunately, randomized controlled trials (RCTs) critically examining
CAMare accumulating [1]. The aimof the present reviewwas to provide
a comprehensive overview of the evidence-based CAM therapies avail-
able for infertility treatment.
2. Materials and methods
A preliminary search of the MEDLINE and Cochrane databases was
performed using the keywords “CAM,” “alternative medicine,” “acu-
puncture,” “acupressure,” and “herbal medicine,” cross-referenced
with “infertility,” “IVF,” and “assisted reproduction.” The results and
their bibliographies were analyzed and used to develop a more exten-
sive search of the MEDLINE database on February 3, 2011, using the
keywords listed in Table 1, with a secondary search completed on
November 3, 2012. These search results were examined for articles
involving acupuncture, herbs and supplements, diet and nutrition,
and psychotherapy and their therapeutic use in infertility. The se-
quence and criteria for exclusion are provided in Fig. 1. RCTs were
included based on use of objective measures, articles written in the
English language after January 1, 1986, and inclusion of clear pub-
lished clinical outcomes. Observational and quasi-experimental stud-
ies were excluded from the review. Given the huge number of studies
on the use of traditional Chinese medicine and the lack of such studiesl Federation of Gynecology and Obstetrics.
Table 1
Search terms.
Main terms Cross-referenced terms
Infertility Acupressure Licorice root
IVF Acupuncture Macrobiotic
Assisted reproduction Antioxidant supplement Massage
Aromatherapy Meditation
Ayurveda Meridians
Bioelectromagnetic Milk thistle
Biofeedback Mind body medicine
Black cohosh Mindfulness
CAM Music therapy
Chasteberry Nutritional supplement
Chinese medicine Oral antioxidant
Chinese yam Phytoestrogen
Chiropractic Primrose oil
Complementary and
alternative medicine
Probiotic
Diet Psychotherapy
Dong quai Qi
Electrophysiology Red clover
Essential fatty acid Reiki
Ethnobotanical Shaman
Ethnobotany Soy
Exercise Spiritual healing
False unicorn Stress
Guided imagery Supplements
Healing touch Tai chi
Herbal TCM
Holistic Therapeutic touch
Homeopathy Traditional healing
Hops flower Vegan
Hypnosis Vegetarian
Integrative medicine Viburnum opulus
Isoflavone Wild yam
Journaling Yoga
Abbreviations: CAM, complementary and alternative medicine; TCM, traditional Chinese
medicine.
203N.A. Clark et al. / International Journal of Gynecology and Obstetrics 122 (2013) 202–206published in English, this modality was excluded from the review.
Owing to the large number of outcomes reported in many of the stud-
ies reviewed, not all results could be included.Search results
1547 articles
1271 articles 
remaining
276 studies not in English
322 studies not on humans
949 articles 
remaining
636 articles 
remaining
313 studies not involving CAM or infertility
482 articles 
remaining
139 articles 
remaining
37 articles remaining
154 review articles
343 not randomized controlled trials
102 not applicable to study after final review
Fig. 1. Search methodology.3. Results
Based on the inclusion criteria, 37 RCTs were included (Fig. 1). The
results are presented according to therapeutic modality.
3.1. Acupuncture
In the past 15 years, several studies have sought to examine the
role of acupuncture as an adjunct to infertility treatment. Acupuncture
is administered in a point-specific manner along “meridians,” which
presumably correlate with energy flow (qi) throughout the body. Acu-
puncture can be administered with or without electrical stimulation
and is occasionally combined with traditional Chinese herbal medi-
cines. A key factor to consider in evaluating the effect of acupuncture
is that, when practiced according to traditional Chinese medicine,
acupoints are selected based on both diagnosis and patient-specific
symptomatology. While RCTs are designed to evaluate therapeutic in-
terventions rigorously, they do not share this individualized approach
and, rather, adhere to a standardized protocol. This standardization,
while essential for enabling statistical analyses, may confound the
demonstrated effect of acupuncture in individual patients.
3.1.1. Male factor infertility
Acupuncture has been examined for its role in male infertility,
primarily among men with abnormal semen parameters. A placebo-
controlled study by Dieterle et al. [4] compared true and placebo acu-
puncture in 57 men with severe oligoasthenospermia. Those who had
true acupuncture experienced significant improvement in total
motile sperm counts but lower semen volume, and pregnancy rates
were not assessed. In another physiologic study of healthy male
volunteers (30–35 years of age) [5], ultrasound Doppler flowmetry
was used to assess differences in testicular blood flow before and
after acupuncture treatment. Improvements in blood flow were
noted in patients who received acupuncture with electrical stimula-
tion (10 Hz) and those who had stimulation administered at points
correlating to genital problems (ST-29 or guilai) [5].
Acupuncturemay have a role for couples seeking a holistic approach
to improving semen quality. However, subsequent placebo-controlled
studies arewarranted to evaluate the precisemechanism of these inter-
ventions and whether they result in greater pregnancy rates.
3.1.2. In vitro fertilization (IVF) and assisted reproductive technology
(ART) outcomes
Acupuncture as an adjunct to IVF has recently been the topic of sev-
eral studies. Although the physiology is poorly understood, a small
study by Ho et al. [6] demonstrated a reduced pulsatility index of uter-
ine arteries when electro-acupuncture was performed twice weekly
until the day before oocyte retrieval. A small study by Magarelli et al.
[7] showed significant changes in serum cortisol and prolactin during
controlled ovarian hyperstimulation among women who received acu-
puncture compared with thosewho did not, which subsequently corre-
lated with higher pregnancy rates in the former group.
Three RCTs have reported benefits of acupuncture as an adjunct to
standard analgesia and anesthesia regimens for oocyte retrieval.
Stener-Victorin et al. [8] first evaluated this in 150 women undergo-
ing IVF and compared the analgesic effects of a paracervical block in
combination with either electro-acupuncture or alfentanil. No differ-
ences were noted in pain from oocyte retrieval. Sator-Katzenschlager
et al. [9] additionally noted benefits of acupuncture in reducing
retrieval-associated pain when added to standard analgesic regimens.
However, the use of acupuncture seems to be limited as an adjunct to
standard regimens; a study by Gejervall et al. [10] comparing electro-
acupuncture with conventional analgesia demonstrated higher pain
scores during and immediately after retrieval among women who re-
ceived acupuncture.
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proving IVF pregnancy rateswas performed in Germany in 2002. Paulus
et al. [11] randomized 160 infertile women (21–43 years of age) under-
going IVF to acupuncture or no acupuncture. Those in the acupuncture
arm had auricular acupuncture at fertility-specific acupoints on
the day of embryo transfer (ET), 25 minutes before and immediately
after the procedure. The control arm underwent ET without adjunct
therapy. The clinical pregnancy rate among those who received acu-
puncture was 42.5%, compared with 23.6% among those who did not
(P = 0.03). This effect was re-demonstrated in 2006 by Westergaard
et al. [12], who reported a clinical pregnancy rate of 39% among
women who underwent acupuncture and 24% among those who did
not (P = 0.038). Several differences in this study are important to high-
light. No auricular acupuncturewas performed, possibly showing less of
a contribution of this particular acupoint. Additionally, a third arm ex-
amining additional acupuncture 2 days after ET showed no added
benefit. A trial by Dieterle et al. [13], however, showed some benefit
of luteal-phase acupuncture versus sham acupuncture, with clinical
pregnancy rates of 33.6% and 15.6%, respectively.
Despite these initial studies showing a positive effect of adjuvant
acupuncture on IVF, subsequent studies have yet to produce similar
results. Smith et al. [14] failed to show improvement in clinical preg-
nancy rate (23% vs 31%) when comparing sham and true acupuncture
on the day of ET. So et al. [15] conducted a similar trial comparing true
acupuncture on the day of ET with placebo acupuncture using blunt
needles; the authors reported higher pregnancy rates in the placebo
group (55.1% vs 43.8%; P = 0.038). Two large infertility groups in
the USA have also recently reported no benefit of adjunct acupunc-
ture. Domar et al. [16] compared true acupuncture with no acupunc-
ture in patients undergoing IVF and reported similar pregnancy rates
(30.8% vs 33.8%). Moy et al. [17] compared true acupuncture with
sham acupuncture in the IVF population and also found no difference
in pregnancy rates (45.3% vs 52.7%); however, theirs was an under-
powered study.
Although results are mixed with regard to the benefits of acupunc-
ture in relation to IVF pregnancy rates, all studies were consistent in
showing no increase in adverse events and several showed improve-
ments in anxiety levels [14,16]. However, it must be remembered that
acupuncture is potentially time consuming and expensive, and it is
not painless; furthermore, there is still no irrefutable evidence from
RCTs to prove its effect. As an IVF adjunct, acupuncture may provide
an alternative approach for improving anxiety and the pain associat-
ed with the procedural aspects of IVF and it may have a positive effect
on pregnancy rates; however, additional studies are warranted.
3.2. Herbs and supplements
Several dietary supplements composed of a variety of herbs and
minerals are commercially available, marketed for use for infertility,
and unregulated by regulatory institutions such as the Food and
Drug Administration. The following is a review of the evidence for
several herbs and supplements used for male and female infertility.
3.2.1. Male factor infertility
Selenium is one of themost studied supplements formale infertility,
and 4 studies have examined its impact on semen parameters. In a die-
tary study of 11 healthy men, participants were fed a diet with varying
concentrations of selenium over a 120-day period [18]. Plasma concen-
trations correlatedwith dietary supplementation, and participants fed a
diet high in seleniumhad 18% decreased totalmotile sperm fraction, de-
creased triiodothyronine, and increased thyroid-stimulating hormone.
This indicates that diets high in seleniummight be associated with de-
creased sperm motility, potentially secondary to effects on thyroid
hormone production. Safarinejad et al. [19] completed a double-blind,
placebo-controlled RCT of 468 healthy men. Participants who were
given selenium together with N-acetylcysteine (NAC) had increasedsperm concentration, spermmotility, and percentage ofmorphological-
ly normal sperm—all of which correlated with seminal concentrations
of selenium and NAC. In another study, 54men were randomized to vi-
tamin E with selenium versus vitamin B alone, with 20 returning for
follow-up [20]. Participants taking vitamin E with selenium were
found to have decreased lipid peroxidation and improved spermmotil-
ity. In a study by Scott et al. [21], men treated with selenium had in-
creased sperm motility but no change in sperm density compared
with those treated with placebo.
Zinc supplementation has also been examined with regard to male
factor infertility. In a dietary study, 11 male volunteers were fed a
zinc-deprived diet for 28 days [22]. They were subsequently noted
to have decreased serum testosterone (26.9 vs 21.9 nmol/L) and de-
creased seminal volumes (3.30 vs 2.24 mL). Another study of infertile
men who smoked cigarettes demonstrated that, compared with pla-
cebo, zinc supplementation improved sperm quality and increased
seminal interleukin-4, while reducing tumor necrosis factor-α and
interferon-γ [23]. As such, it would seem that zinc is an important di-
etary component in the production of semen.
With regard to antioxidants, Keskes-Ammar et al. [20] found that
participants taking vitamin E with selenium had decreased lipid per-
oxidation and improved sperm motility compared with men whose
diets were supplemented with vitamin B. Whether this effect was
secondary to the selenium or the vitamin E is unknown. Additionally,
Kessopoulou et al. [24] demonstrated that oral vitamin E improved
the in vitro function of human spermatozoa, as assessed by zona-
binding test. Thus, it seems that vitamin E supplementation may
have some promise in improving semen parameters; however, more
evidence is needed. A proprietary antioxidant preparation, Menevit
(Bayer Australia, Pymble, New South Wales, Australia), was studied
by Tremellen et al. [25]. It was found to improve pregnancy rates
(38.5% vs 16%; P b 0.05) but not oocyte fertilization rates or embryo
quality among couples undergoing IVF-intracytoplasmic sperm injec-
tion. Safarinejad et al. [26] examined semen parameters in infertile
men supplemented with the antioxidant coenzyme Q10. Supplemen-
tation was associated with an improvement in sperm density, motil-
ity, count, and morphology, as well as an increased mean acrosome
reaction. There was no effect on pregnancy rate.
Shahin et al. [27] examined the use of Indian ginseng (Withania
somnifera; 5 g per day orally for 3 months), which is commonly
used in Ayurvedic medicine for infertility. Participants were noted
to have decreased levels of oxidants and improved levels of antioxi-
dants and vitamins A, C, and E in seminal plasma. Additionally, they
had increased levels of testosterone, luteinizing hormone, follicle-
stimulating hormone, and prolactin (P b 0.05) following treatment.
Thus, Indian ginseng may offer some benefit for the treatment of
male factor infertility.
Overall, upon examining many supplements for male factor infer-
tility, the breadth of possibilities and the lack of data confirming effi-
cacy are apparent. There is at least preliminary evidence for the use of
selenium, zinc, and Indian ginseng, as well as a wealth of antioxidants
such as vitamin E and coenzyme Q10, to improve semen parameters.
How these supplements directly affect subsequent pregnancy and
birth rates has yet to be determined.
3.2.2. Female factor infertility
Multiple vitamin and herbal supplements have been examinedwith
regard to their effect on female infertility. Many herbal preparations—
a large number of which contain phytoestrogens—are marketed
purporting positive fertility effects. Black cohosh (Cimicifuga racemosa)
is a phytoestrogen-containing herbaceous flowering plant native to the
USA. A primary study by Shahin et al. [28] demonstrated that, inwomen
with unexplained infertility who were undergoing clomiphene induc-
tion, those supplemented with black cohosh (120 mg per day, cycle
days 1–12) had increased levels of luteinizing hormone, progesterone,
and estradiol, in addition to increased endometrial thickness and
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controls. In a subsequent study, Shahin et al. [27] compared follicular-
phase black cohosh supplementation with ethinyl estradiol supple-
mentation; black cohosh improved endometrial thickness, follicular
maturation, and estradiol levels among coupleswith unexplained infer-
tility undergoing clomiphene induction. There was no statistically sig-
nificant difference in clinical pregnancy rates (14.0% versus 21.1%). In
a study by Unfer et al. [29], women treated with both progesterone
and phytoestrogens for luteal-phase support were found to have higher
rates of implantation (25.4% vs 20.2%), clinical pregnancy (39.3% vs
20.9%), and delivery (30.3% vs 16.2%) compared with controls.
A study by Westphal et al. [30] found that nutritional supplemen-
tation with FertililtyBlend (DailyWellness, Honolulu, HI, USA)—a pro-
prietary nutritional supplement containing chasteberry and green tea
extracts, L-arginine, vitamins, and minerals—increased the average
number of days in the cycle in which basal temperatures were greater
than 37 °C during the luteal phase and increased pregnancy rates
after 5 months of supplementation compared with controls (26% vs
10%; P = 0.01).
A single study on the use of intravaginal probiotics immediately
after oocyte retrieval met inclusion criteria. In this RCT of vaginal
probiotic supplementation versus placebo, Gilboa et al. [31] found
that probiotic supplementation immediately after oocyte retrieval
had no effect on vaginal colonization or pregnancy rate in IVF cycles
[31]. Thus, there is limited evidence that some herbal preparations
improve pregnancy rates; however, more studies must be completed
to prove safety and efficacy.3.3. Diet and nutrition
Three studies examining diet and nutrition—focusing primarily on
weight loss interventions in obese infertile women—met review
criteria. Weight loss as small as 5%–10% of body weight has been
shown to improve reproductive function in obese patients with poly-
cystic ovary syndrome (PCOS) [32]; however, the best methods for
weight loss in these patients have not yet been determined. Addition-
ally, fertility-enhancing medications might not be necessary for
patients who can successfully restore their reproductive function
through weight loss.
A primary intervention examined was the impact of low-calorie
diets. Stamets et al. [33] investigated the effects of 2 different low-
calorie diets in 26 obese infertile women with PCOS over 1 month.
Participants were randomized to a diet high in either protein or car-
bohydrate, and all diets were designed to create a 1000-kcal deficit
per day. Women in both groups experienced significant weight
loss, without any significant differences noted between the diets.
Women in both groups were also noted to have a significant decrease
in testosterone, fasting insulin, insulin-to-glucose ratio, circulating
leptin, total cholesterol, and low-density lipoprotein (LDL). Clinical
markers of reproductive function, such as ovulation or pregnancy
rates, were not reported.
Karimzadeh and Javedani [34] studied 343 overweight and infer-
tile PCOS patients; the women were randomized to treatment with
lifestyle modification (low-calorie diet and exercise), clomiphene
alone, metformin alone, or clomiphene with metformin for 8 months.
The authors reported no significant differences between the groups in
terms of menstrual cycles or clinical pregnancy rates. There was a sig-
nificantly higher rate of multiple pregnancies in the groups taking
clomiphene, with or without metformin. The lifestyle intervention
group also showed a significant reduction in waist circumference, in-
sulin, and LDL compared with the other 3 groups.
Galletly et al. [35] investigated the stimulant dexfenfluramine versus
placebo as an adjunct to a weight-loss program in 21 obese infertile
women. Women in both groups demonstrated weight loss, improved
self-esteem, and diminished anxiety and depression; however, therewere no significant differences between dexfenfluramine and placebo
in terms of these measures.
The combination of a healthy diet and weight loss are broadly
beneficial to women’s health, and the available evidence demon-
strates that improved hormonal parameters from diet and exercise
are at least equivalent to those from medication use. Given this
array of benefits, it would be reasonable to consider lifestyle modifi-
cations aimed at weight loss in the treatment armamentarium for
obese women with PCOS.
3.4. Psychotherapy
Women undergoing infertility treatment report higher levels of
anxiety, depression, and emotional stress compared with those who
conceive naturally [36]. Many couples undergoing infertility treat-
ment seek counseling as a form of emotional support, and many stud-
ies have examined the effect of counseling on reducing anxiety and
depression, and improving pregnancy rates. In a Chinese study [37],
4 sessions of eastern body–mind–spirit group counseling effectively
reduced the anxiety level of women undergoing IVF, with a nonsignif-
icant trend toward a higher pregnancy rate compared with controls
who did not receive counseling. A study by Hosaka et al. [38] demon-
strated that 5 sessions of psychiatric group intervention resulted in
decreased psychological discomfort, decreased inflammation (denot-
ed by natural killer cell activity), and higher pregnancy rate compared
with controls (37.8% vs 13.5%).
In a study by Domar et al. [39], participants receiving emotion-
focused psychological intervention reported less depression and more
infertility-specific wellbeing compared with controls at 1 month. At
1 year, participants in the group receiving problem-focused psycholog-
ical intervention were more likely to have a viable pregnancy than par-
ticipants in both other groups (55% problem focused, 54% emotion
focused, 20% control). Thus, it would appear that counseling might
have a positive impact on pregnancy rate. However, these findings are
contradicted by a study by de Klerk et al. [40] in which the pregnancy
rate among couples who received 3 sessions of experimental psychoso-
cial therapy during their first IVF cycle was not statistically different
from that among controls who did not receive psychotherapy [40].
Thus, while counseling demonstrates no adverse effects and might be
effective for improving psychological wellbeing among infertility pa-
tients, there is an unclear effect on improving reproductive parameters.
4. Discussion
Despite limited data and relatively few RCTs of CAM interventions
for infertility, there is preliminary evidence to suggest that some of
these modalities may be effective adjuncts in fertility treatment. At
least 3 clinical trials with consistent results have examined the use
of acupuncture, selenium supplementation, weight loss, and psycho-
therapy. It seems that acupuncture and psychotherapy have at least
some effect on the psychological wellbeing of patients undergoing in-
fertility treatment, and some studies show a nonsignificant trend to-
ward increased pregnancy rates; however, additional studies must
be completed to confirm these trends. Selenium supplementation
may have some role in improving semen parameters, potentially
through modulation of thyroid hormone, but evidence is limited
and there remain conflicting results. Additionally, for obese patients
with PCOS, lifestyle modifications—including low-calorie diets—
aimed at weight loss could be considered. There is little evidence for
dietary intervention for patients without PCOS.
While the present study reviewed the available RCTs on CAM
treatment for infertility, methodological issues are remarkably perva-
sive in these studies, and brevity precludes their full discussion. The
results discussed were selected by the present authors, and additional
evidence should be examined where interest warrants. Similarly,
the individualized nature of many CAM modalities prohibits a
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meditation and mindfulness, massage, exercise, or online-based sup-
port groups met inclusion criteria. Additionally, the present review
was restricted to studies published in the English language, which
could have limited a full assessment of the spectrum of CAM, particu-
larly in the areas of ethnobotany and traditional Chinese medicine.
Complementary and alternative medicine is commonly used in
much of the world and is gaining in popularity in western medical
practice. Often, patients’ use of CAM arises from their cultural norms
or their dissatisfaction with access to, effectiveness of, or cultural
appropriateness of available biomedical treatments [2]. As data
pertaining to the biomedical effectiveness of these modalities contin-
ue to lag behind patients’ enthusiastic use of CAM, practitioners caring
for infertile patientswill increasingly be called upon to individually as-
sess the safety and efficacy of CAM. Certainly, superior RCTs regarding
CAM interventions are called for so that simple, precise, quantitative,
and irrefutable evidence could place CAM in a scientifically earned
place. As such, continued investigation into the demonstrable benefits
and risks of thesemedicines and therapies is needed to best serve infer-
tile patients and evaluate the use of routine clinical recommendation.
Conflict of interest
The authors have no conflicts of interest.
References
[1] Vickers A. Recent advances: complementary medicine. BMJ 2000;321(7262):
683–6.
[2] Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during
pregnancy. Obstet Gynecol 2005;105(5 Pt 1):1119–22.
[3] Zollman C, Vickers A. What is complementary medicine? BMJ 1999;319(7211):
693–6.
[4] Dieterle S, Li C, Greb R, Bartzsch F, Hatzmann W, Huang D. A prospective random-
ized placebo-controlled study of the effect of acupuncture in infertile patients
with severe oligoasthenozoospermia. Fertil Steril 2009;92(4):1340–3.
[5] Cakmak YO, Akpinar IN, Ekinci G, Bekiroglu N. Point- and frequency-specific
response of the testicular artery to abdominal electroacupuncture in humans.
Fertil Steril 2008;90(5):1732–8.
[6] Ho M, Huang LC, Chang YY, Chen HY, Chang WC, Yang TC, et al. Electro-
acupuncture reduces uterine artery blood flow impedance in infertile women.
Taiwan J Obstet Gynecol 2009;48(2):148–51.
[7] Magarelli PC, Cridennda DK, Cohen M. Changes in serum cortisol and prolactin
associated with acupuncture during controlled ovarian hyperstimulation in
women undergoing in vitro fertilization-embryo transfer treatment. Fertil Steril
2009;92(6):1870–9.
[8] Stener-Victorin E, Waldenström U, Nilsson L, Wikland M, Janson PO. A prospective
randomized study of electro-acupuncture versus alfentanil as anaesthesia during
oocyte aspiration in in-vitro fertilization. Hum Reprod 1999;14(10):2480–4.
[9] Sator-Katzenschlager SM, Wölfler MM, Kozek-Langenecker SA, Sator K, Sator PG,
Li B, et al. Auricular electro-acupuncture as an additional perioperative analgesic
method during oocyte aspiration in IVF treatment. Hum Reprod 2006;21(8):
2114–20.
[10] Gejervall AL, Stener-Victorin E, Möller A, Janson PO, Werner C, Bergh C. Electro-
acupuncture versus conventional analgesia: a comparison of pain levels during
oocyte aspiration and patients’ experiences of well-being after surgery. Hum
Reprod 2005;20(3):728–35.
[11] Paulus WE, Zhang M, Strehler E, El-Danasouri I, Sterzik K. Influence of acupunc-
ture on the pregnancy rate in patients who undergo assisted reproduction thera-
py. Fertil Steril 2002;77(4):721–4.
[12] Westergaard LG, Mao Q, Krogslund M, Sandrini S, Lenz S, Grinsted J. Acupuncture
on the day of embryo transfer significantly improves the reproductive outcome in
infertile women: a prospective, randomized trial. Fertil Steril 2006;85(5):1341–6.
[13] Dieterle S, Ying G, HatzmannW, Neuer A. Effect of acupuncture on the outcome of
in vitro fertilization and intracytoplasmic sperm injection: a randomized, pro-
spective, controlled clinical study. Fertil Steril 2006;85(5):1347–51.
[14] Smith C, Coyle M, Norman RJ. Influence of acupuncture stimulation on pregnancy
rates for women undergoing embryo transfer. Fertil Steril 2006;85(5):1352–8.[15] So EW, Ng EH, Wong YY, Lau EY, Yeung WS, Ho PC. A randomized double blind
comparison of real and placebo acupuncture in IVF treatment. Hum Reprod
2009;24(2):341–8.
[16] Domar AD, Meshay I, Kelliher J, Alper M, Powers RD. The impact of acupuncture
on in vitro fertilization outcome. Fertil Steril 2009;91(3):723–6.
[17] Moy I, Milad MP, Barnes R, Confino E, Kazer RR, Zhang X. Randomized controlled
trial: effects of acupuncture on pregnancy rates in women undergoing in vitro
fertilization. Fertil Steril 2011;95(2):583–7.
[18] Hawkes WC, Turek PJ. Effects of dietary selenium on sperm motility in healthy
men. J Androl 2001;22(5):764–72.
[19] Safarinejad MR, Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for
improving semen parameters in infertile men: a double-blind, placebo controlled,
randomized study. J Urol 2009;181(2):741–51.
[20] Keskes-Ammar L, Feki-Chakroun N, Rebai T, Sahnoun Z, Ghozzi H, Hammami S,
et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium
supplement on semen quality in infertile men. Arch Androl 2003;49(2):83–94.
[21] Scott R, MacPherson A, Yates RW, Hussain B, Dixon J. The effect of oral selenium
supplementation on human sperm motility. Br J Urol 1998;82(1):76–80.
[22] Hunt CD, Johnson PE, Herbel J, Mullen LK. Effects of dietary zinc depletion on
seminal volume and zinc loss, serum testosterone concentrations, and sperm
morphology in young men. Am J Clin Nutr 1992;56(1):148–57.
[23] Al-Bader A, Omu AE, Dashti H. Chronic cadmium toxicity to sperm of heavy ciga-
rette smokers: immunomodulation by zinc. Arch Androl 1999;43(2):135–40.
[24] Kessopoulou E, Powers HJ, Sharma KK, Pearson MJ, Russell JM, Cooke ID, et al. A
double-blind randomized placebo cross-over controlled trial using the antioxi-
dant vitamin E to treat reactive oxygen species associated male infertility. Fertil
Steril 1995;64(4):825–31.
[25] Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examin-
ing the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI
treatment. Aust N Z J Obstet Gynaecol 2007;47(3):216–21.
[26] Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function
and reproductive hormones in infertile men. J Urol 2009;182(1):237–48.
[27] Shahin AY, Ismail AM, Shaaban OM. Supplementation of clomiphene citrate cycles
with Cimicifuga racemosa or ethinyl oestradiol—a randomized trial. Reprod
Biomed Online 2009;19(4):501–7.
[28] Shahin AY, Ismail AM, Zahran KM, Makhlouf AM. Adding phytoestrogens to clo-
miphene induction in unexplained infertility patients—a randomized trial. Reprod
Biomed Online 2008;16(4):580–8.
[29] Unfer V, Casini ML, Gerli S, Costabile L, Mignosa M, Di Renzo GC. Phytoestrogens
may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles:
a prospective, controlled, randomized trial. Fertil Steril 2004;82(6):1509–13.
[30] Westphal LM, Polan ML, Trant AS, Mooney SB. A nutritional supplement for
improving fertility in women: a pilot study. J Reprod Med 2004;49(4):289–93.
[31] Gilboa Y, Bar-Hava I, Fisch B, Ashkenazi J, Voliovitch I, Borkowski T, et al.
Does intravaginal probiotic supplementation increase the pregnancy rate in
IVF-embryo transfer cycles? Reprod Biomed Online 2005;11(1):71–5.
[32] Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improve-
ment in endocrine and ovarian function during dietary treatment of obese
women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;36(1):
105–11.
[33] Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS. A random-
ized trial of the effects of two types of short-term hypocaloric diets on weight loss
in women with polycystic ovary syndrome. Fertil Steril 2004;81(3):630–7.
[34] Karimzadeh MA, Javedani M. An assessment of lifestyle modification versus med-
ical treatment with clomiphene citrate, metformin, and clomiphene citrate-
metformin in patients with polycystic ovary syndrome. Fertil Steril 2010;94(1):
216–20.
[35] Galletly C, Clark A, Tomlinson L. Evaluation of dexfenfluramine in a weight loss
program for obese infertile women. Int J Eat Disord 1996;19(2):209–12.
[36] Vahratian A, Smith YR, Dorman M, Flynn HA. Longitudinal depressive symptoms
and state anxiety among women using assisted reproductive technology. Fertil
Steril 2011;95(3):1192–4.
[37] Chan CH, Ng EH, Chan CL, Ho, Chan TH. Effectiveness of psychosocial group
intervention for reducing anxiety in women undergoing in vitro fertilization: a
randomized controlled study. Fertil Steril 2006;85(2):339–46.
[38] Hosaka T, Matsubayashi H, Sugiyama Y, Izumi S, Makino T. Effect of psychiatric
group intervention on natural-killer cell activity and pregnancy rate. Gen Hosp
Psychiatry 2002;24(5):353–6.
[39] Domar AD, Clapp D, Slawsby EA, Dusek J, Kessel B, Freizinger M. Impact of group
psychological interventions on pregnancy rates in infertile women. Fertil Steril
2000;73(4):805–11.
[40] de Klerk C, Hunfeld JA, Duivenvoorden HJ, den Outer MA, Fauser BC, Passchier J,
et al. Effectiveness of a psychosocial counseling intervention for first-time IVF
couples: a randomized controlled trial. Hum Reprod 2005;20(5):1333–8.
